Role of melanin-concentrating hormone in drug use disorders.


Journal

Brain research
ISSN: 1872-6240
Titre abrégé: Brain Res
Pays: Netherlands
ID NLM: 0045503

Informations de publication

Date de publication:
15 08 2020
Historique:
received: 19 10 2019
revised: 17 04 2020
accepted: 28 04 2020
pubmed: 4 5 2020
medline: 2 9 2021
entrez: 4 5 2020
Statut: ppublish

Résumé

Melanin-concentrating hormone (MCH) is a neuropeptide primarily transcribed in the lateral hypothalamus (LH), with vast projections to many areas throughout the central nervous system that play an important role in motivated behaviors and drug use. Anatomical, pharmacological and genetic studies implicate MCH in mediating the intake and reinforcement of commonly abused substances, acting by influencing several systems including the mesolimbic dopaminergic system, glutamatergic as well as GABAergic signaling and being modulated by inflammatory neuroimmune pathways. Further support for the role of MCH in controlling behavior related to drug use will be discussed as it relates to cerebral ventricular volume transmission and intracellular molecules including cocaine- and amphetamine-regulated transcript peptide, dopamine- and cAMP-regulated phosphoprotein 32 kDa. The primary goal of this review is to introduce and summarize current literature surrounding the role of MCH in mediating the intake and reinforcement of commonly abused drugs, such as alcohol, cocaine, amphetamine, nicotine and opiates.

Identifiants

pubmed: 32360868
pii: S0006-8993(20)30228-6
doi: 10.1016/j.brainres.2020.146872
pii:
doi:

Substances chimiques

Hypothalamic Hormones 0
Melanins 0
Neuropeptides 0
Pituitary Hormones 0
melanin-concentrating hormone 67382-96-1

Types de publication

Journal Article Research Support, N.I.H., Extramural Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

146872

Subventions

Organisme : NIAAA NIH HHS
ID : R01 AA024798
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Auteurs

Irene Morganstern (I)

Behavioral Pharmacology, PsychoGenics, Paramus, NJ 07652, USA.

Gazal Gulati (G)

Laboratory of Behavioral Neurobiology, The Rockefeller University, New York, NY 10065, USA.

Sarah F Leibowitz (SF)

Laboratory of Behavioral Neurobiology, The Rockefeller University, New York, NY 10065, USA. Electronic address: leibow@mail.rockefeller.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH